Company: PFSA
Filing Date: 2025-09-17
Form Type: S-1/A
Source: 0001213900-25-088333
Chunk: 365

Company: Profusa, Inc.
Filing Date: 2025-09-17
Form: S-1/A
Chunk 365
---
 whether to require all holders to exercise their warrants on a “cashless basis,” management will consider, among other factors, the Company’s cash position, the number of warrants that are outstanding and the dilutive effect on the stockholders of issuing the maximum number of shares of common stock issuable upon the exercise of the warrants. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. Note 4 — Private Placement The Company’s Sponsor, I -Bankersand Dawson James have purchased an aggregate of 7,347,500Private Placement Warrants (which included 697,500Private Placement Warrants issued pursuant to the full exercise of the over -allotmentoption) at a price of $ 1.00per warrant ($ 7,347,500in the aggregate) in a private placement that closed simultaneously with the closing of the IPO. Of such amount, 5,162,500Private Placement Warrants were purchased by the Sponsor and 2,185,000Private Placement Warrants were purchased by I -Bankersand Dawson James. The Private Placement Warrants are identical to the warrants included in the units sold in the IPO, except that the Private Placement Warrants: (i) will not be redeemable by the Company and (ii) may be exercised for cash or on a cashless basis, in each case so long as they are held by the initial purchasers or any of their permitted transferees. If the Private Placement Warrants are held by holders other than the initial purchasers or any of their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the Units being sold in the IPO. Note 5 — Related Party Transactions Founder Shares In April 2021, the Sponsor paid $ 25,000, or approximately $ 0.005per share, to cover certain of the offering costs in exchange for an aggregate of 5